1. Peptides


Peptides (225):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-16658
    Z-VAD-FMK 187389-52-2 >98.0%
    Z-VAD-FMK is a cell-permeable, pan-caspase inhibitor.
  • HY-13948
    Angiotensin II human 4474-91-3 99.34%
    Angiotensin II human is converted by Angiotensin I through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE). Angiotensin II is mediated by AT1 and AT2 receptors, which are seven transmembrane glycoproteins with 30% sequence similarity.
    Angiotensin II human
  • HY-13443
    Exendin-4 141758-74-9 98.96%
    Exendin-4, a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM.
  • HY-17365
    Octreotide acetate 79517-01-4 98.82%
    Octreotide (acetate) is a long-acting octapeptide and somatostatin analog with pharmacologic actions mimicking those of the natural hormone somatostatin.
    Octreotide acetate
  • HY-A0190
    Ceruletide 17650-98-5 98.09%
    Ceruletide (Caerulein) is a biologically active decapeptide isolated from the skin of the Australian frog Hyla caerulea. It is a potent cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts in humans and
  • HY-12403
    Angiotensin 1-7 51833-78-4 98.62%
    Angiotensin (1-7) inhibits purified canine angiotensin converting enzyme (ACE) activity with an IC50 of 0.65 μM.
    Angiotensin 1-7
  • HY-P0018
    Pepstatin 26305-03-3 98.45%
    Pepstatin is a potent inhibitor of aspartyl proteases, and inhibits the aspartic proteases cathepsin D, pepsin, and renin.
  • HY-P0017
    Aprotinin 9087-70-1 99.56%
    Aprotinin is a serine protease inhibitor isolated from bovine lung which inhibits trypsin and chymotrypsin with Ki values of 0.06 pM and 9 nM, respectively.
  • HY-12290
    Arg-Gly-Asp-Ser 91037-65-9 >98.0%
    Arg-Gly-Asp-Ser is an integrin binding sequence that inhibits integrin receptor function, decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, iNOS and MMP-9.
  • HY-P0069
    D-JNKI-1 is a specific inhibitor of JNK, and strongly interferes with JNK activation.
  • HY-P0081
    Bax inhibitor peptide V5 579492-81-2 99.79%
    Bax inhibitor peptide V5 is a Bax-mediated apoptosis inhibitor, used for cancer treatment.
    Bax inhibitor peptide V5
  • HY-P0014
    Liraglutide 204656-20-2 99.96%
    Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
  • HY-18234A
    Leupeptin hemisulfate 103476-89-7 >98.0%
    Leupeptin hemisulfate is a reversible, competitive serine/cysteine protease inhibitor, which has been shown to inhibit cathepsins B, H, L, and S, calpain, and trypsin.
    Leupeptin hemisulfate
  • HY-P0023
    Cyclo(-RGDfK) 161552-03-0 >98.0%
    Cyclo(-RGDfK) is a potent and selective inhibitor of the αvβ3 integrin.
  • HY-P0117
    Tat-NR2B9c 500992-11-0 98.22%
    Tat-NR2B9c is a PSD95 inhibitor with EC50 of 7 nM, also inhibit p38. Tat-NR2B9c blocks NMDA-induced superoxide formation by prevents phosphorylation of the NOX2 p47phoxsubunit.
  • HY-P0072
    Microcystin-LR 101043-37-2
    Microcystin-LR inhibits protein phosphatase type 1 and type 2A (PP1 and PP2A) activities in the cytoplasm of liver cells.
  • HY-41189
    Fmoc-Val-Cit-PAB-PNP 863971-53-3
    Fmoc-Val-Cit-PAB-PNP is a peptide prodrug linker, is a linker for antibody-drug-conjugation (ADC).
  • HY-P0082
    Glucagon 16941-32-5
    Glucagon is a peptide hormone, exhibits therapeutic potential for metabolic disease.
  • HY-13665
    Leuprolide Acetate 74381-53-6 99.88%
    Leuprolide acetate (Leuprorelin) is a GnRH analog; leuprolide acetate acts as an agonist at pituitary GnRH receptors.
    Leuprolide Acetate
  • HY-P0073
    Tyr-Gly-Gly-Phe-Met-OH 58569-55-4 99.89%
    Tyr-Gly-Gly-Phe-Met-OH (Methionine enkephalin) is synthetic opioid peptides.